FDA questions use of aspirin for primary prevention of stroke and heart attackBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3168 (Published 08 May 2014) Cite this as: BMJ 2014;348:g3168
- Michael McCarthy
Aspirin should not be routinely used for the primary prevention of heart attack or stroke in patients with no history of cardiovascular disease, the US Food and Drug Administration has concluded.
“The FDA has reviewed the available data and does not believe the evidence supports the general use of aspirin for primary prevention of a heart attack or stroke,” it said in a statement posted online last week.1
“In fact, there are serious risks associated with the use of aspirin, including increased …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial